Northern Lithuania College

Like backups, replication is top of mind for many DBAs across the globe. Properly built replication architectures ensure increased data availability, thus making it a fundamental strategy for database architectures as well as disaster recovery. However, as fundamental as replication may seem, one should consider both the benefits and drawbacks of such an appliance.

For many, the usage of MySQL is a means to an end – some of us create websites, while applications may take the cake for others. No matter what your specific use case is, you will need to make good use of storage engines within its infrastructure.

To identify the level of provision of reproductive and sexual health (RSH) services to reproductive-age women enrolled in opioid treatment programs (OTPs) in 2017, and to understand provider-perceived barriers to integration of services. A web-based survey was sent to medical or program directors at all OTPs (n = 48) in North Carolina (NC). Data were collected regarding program characteristics, demographic information about female patient populations, provision of RSH services, and provider-perceived barriers to service integration into OTPs. Survey results were aggregated for descriptive analysis. The survey response rate was 79%, representing 38 out of the 48 OTPs. Among OTPs, 95% serve pregnant and parenting women, 21% have female-specific programs, and together they serve a total of about 5000 women annually. Medical and program directors reported that approximately 53% of women have 1 or more children, and 6.5% are, at present, pregnant. Nearly 90% of programs provide pregnancy testing, but only about 50% provide contraception. Although more than half offer hepatitis C virus (HCV) testing, less than half offer human immunodeficiency virus (HIV) testing and sexually transmitted infection (STI) testing. Half of the programs provide education about STI prevention and safer sex practices. Most medical and program directors (84%) perceive female patients could benefit from RSH education and more than two-thirds (68%) perceive female patients need increased access to RSH services. Provider-perceived barriers to service integration include lack of facility equipment and supplies, trained staff, and childcare. NC OTPs are a logical setting for integrating RSH services to meet the needs of reproductive-age women in treatment for OUD.

Namen prispevka je umestitev poročila Mednarodne komisije za proučevanje komunikacijskih problemov Mnogo glasov, en svet (bolj znano kot MacBridovo poročilo), v zgodovinski, družbeni, političnoekonomski in intelektualni kontekst njegovega nastanka. Poročilo velja za eno najpomembnejših intervencij na področju mednarodnega komuniciranja, ki si je za cilj zastavilo zmanjševanje neenakosti v dostopu do komunikacijskih sredstev tako med državami kot znotraj držav. Prispevek izhaja iz predpostavke, da sta kritična misel in poizkus njenega prenosa v praktične rešitve neizogibno pogojena s širšim družbenim kontekstom. To se kaže tako v primeru MacBridovega poročila kot tudi v razvoju politične ekonomije komuniciranja, ki je tvorila temelje za pobudo za novo svetovno informacijsko in komunikacijsko ureditev, katere najpomembnejši dokument je prav MacBridovo poročilo.The aim of this article is to situate the report of the International Commission for the Study of Communication Problems Many Voices, One World (more commonly known as the MacBride report) within its historic, social, political-economic and intellectual context. The report is regarded as one of the seminal interventions in the field of international communication, and aimed to reduce inequalities in the access to means of communication between countries as well as within them. The article argues that critical thought and its practical application are necessarily conditioned by the wider social context. This is evident in the case of the MacBride report as well as in the development of political economy of communication, which formed the basis of the call for a New World Information and Communication Order and of its most important document, the MacBride report.

Linezolid is an effective and well-tolerated antibiotic for the treatment of Gram-positive infections, including hospital and community-acquired pneumonia and complicated and uncomplicated skin and skin structure infections. In adults linezolid treatment for >/=2 weeks has been associated with reversible hematopoietic suppression, primarily thrombocytopenia. To evaluate the occurrence of hematologic effects in children with Gram-positive infections in an open label study of linezolid vs. vancomycin. Detailed analyses of hematologic data, including reported hematologic adverse events, complete blood counts, reticulocyte index (RI) and iron studies (serum iron and transferrin saturation), were conducted in both groups at baseline and during and after treatment with the use of an intent-to-treat analysis. Three hundred sixteen patients (median age, 1.65 yr) randomized 2:1 to linezolid (n = 215) or vancomycin (n = 101) were treated. Total treatment durations were similar in the vancomycin group (12.2 +/- 6.4 days; median, 11.0 days) and the linezolid group (11.3 +/- 5.0 days; median, 11.0 days) (P = 0.20). No significant differences were noted in drug-related hematologic events, such as thrombocytopenia (linezolid, 1.9% vs. vancomycin, 0%; P = 0.170), anemia (linezolid, 1.4% vs. vancomycin, 1.0%; P = 0.771) or neutropenia (linezolid, 0% vs. vancomycin, 0%). Hemoglobin values also were similar between treatment groups when assessed by shifts from baseline to lowest recorded value. Frequency of occurrence of any substantially abnormal value for hemoglobin (15.7% vs. 12.4%), platelets (12.9% vs. 13.4%) and neutrophils (5.9% vs. 4.3%) were similar in the linezolid and vancomycin groups. No clinically relevant changes in RI or iron studies were noted between treatment groups, and parallel increases in RI occurred with both linezolid and vancomycin. No significant differences in hematologic profiles between linezolid and vancomycin occurred in this pediatric population.